In 2004, the concept of immunoediting was described to explain the relationship between the tumor and its microenvironment, involving an elimination phase, equilibrium phase, and the immune evasion phase [37] (Figure 1: Tumor microenvironment in NSCLC with wild type ALK). Here, ALK is linked to non-small cell lung carcinoma.